Lomond Therapeutics
- Business Model
- B2B
- Website
- lomondther.com
- Total Funding
- $64.0M
- Last Round
- $20.0M Venture RoundMar 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Lomond Therapeutics is a small molecule oncology drug discovery company committed to defeating and curing cancer. Many malignant tumors develop resistance to treatment through mutations or escape mechanisms that limit current therapeutics, so Lomond develops differentiated small molecules targeting the fundamental biological pathways behind that resistance in hematologic malignancies. By pursuing pan-variant therapies that address the major drivers of cancer resistance, the company aims to overcome the limitations of existing oncology treatments and deliver first-in-class and best-in-class therapeutics for hematologic malignancies.
Summary
Lomond Therapeutics is a Biotech company. It has raised $64.0M in total across 2 rounds, most recently a $20.0M Venture Round in Mar 2025. Investors include Yosemite, OrbiMed and Deerfield Management.
Funding History
Mar 2025
Sign up to see all 2 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lomond-therapeutics"><img src="https://indexed.vc/api/badge/company/lomond-therapeutics" alt="Lomond Therapeutics on Indexed.vc" width="260" height="76" /></a>